Process for producing optically active gamma-butyrolactone derivatives

Abstract: A process for producing an optically active γ-butyro lactone derivative (II): wherein R¹ is C₁₋₁₀ alkyl or substituted or unsubstituted phenyl comprises enantioselectively hydrogenating a γ-keto acid or an ester thereof (I): wherein R² is hydrogen atom or lower alkyl, in the presence of an optically active ruthenium-phosphine complex. The compounds (I) can be obtained at high optical purity through simple operations and a reduced number of steps, and are useful as insect pheromones or perfumes.

Description: This invention relates to a process for producing optically active γ-butyrolactone derivatives which are important as insect pheromones and perfumes. Many optically active lactone derivatives represented by formula (II): wherein R 1 represents an alkyl group having from 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group; and * indicates an asymmetric carbon atom, are important per se as various insect pheromones or perfumes. Known processes for synthesizing these compounds include (1) a process starting with naturally occurring optically active substances (see Agric. Biol. Chem. , Vol. 51, p. 635 (1987)), (2) a process comprising reduction of γ-keto acids by using yeast (see Appl. Microbiol. , Vol. 11, p. 389 (1963)), and (3) a process comprising optical resolution of racemates (see JP-A-55-43053; the term "JP-A" as used herein means an "unexamined published Japanese patent application"). With respect to process (3), it is known that racemic γ -butyrolactone is obtained by, for example, hydrogenating maleic acid and/or maleic anhydride in the presence of a ruthenium catalyst, such as a phosphonium chloride, primary to tertiary phosphine hydrochloride or quaternary phosphonium hydrochloride complex of ruthenium (see JP-A-2-200680). Process (1) using a naturally occurring substance as a starting material involves many steps and complicated operations. Process (2) using micro-organisms has not yet succeeded in achieving high optical purity. Process (3) is disadvantageous in that an equivalent amount of an optically active compound is required and that the resolution efficiency reached is poor. The use of chiral ruthenium-phosphine complexes for the homogeneous asymmetric hydrogenation of several functionalized ketones has been discussed previously by, for example, Kitamura et al [Journal of the American Chemical Society Vol. 110, no. 2, pages 629-631]. Further, Noyori et al discussed [Journal of the American Chemical Society Vol. 109, no. 19, pages 5856-5858] a process for producing an optically active alcohol by asymmetrically hydrogenating a β-keto ester in the presence of such a ruthenium-phosphine complex, which is also discussed by Fieser [in Fieser and Fiesers Reagents for organic synthesis Vol. 14 pages 38-44]. Furthermore, Kawano et al discussed [Journal of the Chemical Society, Chem. Con. 1988, no. 2, pages 87-88] ruthenium-BINAP catalysed hydrogenation of 1,3-diketones gives 1,3-diols with high diastereo- and enantio-selectivity. Still further, Ikariya et al discussed [Journal of the Chemical Society, Chem. Con. 1985, no. 13, pages 299-293] that new chiral ruthenium (II) complexes Ru 2 Cl 4 (BINAP) 2 (NEt 3 ) and Ru 2 Cl 4 (p-tolyl-BINAP) 2 (NEt 3 ) respectively, serve as catalysts for asymmetric hydrogenation of alkenes and some cyclic anhydrides. However, the compounds obtained by the processes discussed in this paragraph are optically active alcohols, and not optically active lactones as produced in the present invention. Hence, there has been a demand for a process for synthesizing a desired optically active γ-butyrolactone derivative at a higher optical purity through a reduced number of steps. In the light of the circumstances stated above, the inventors have conducted extensive investigations and, as a result, found that a lactone derivative of formula (II) having a high optical purity can be obtained through simple operations and a reduced number of steps by enantioselectively hydrogenating a γ-keto acid or an ester thereof in the presence of a relatively cheap optically active ruthenium catalyst. The process according to the present invention is illustrated by the following reaction scheme: wherein R 1 is as defined above; R 2 represents a hydrogen atom or a lower alkyl group (e.g. one having from 1 to 4 carbon atoms); and * indicates an asymmetric carbon atom. The γ-keto acid or ester thereof (I) which is used in the present invention as a starting compound can usually easily be synthesized by the process disclosed in Jean Mathieu and Jean Weill-Rayal, Formation of C-C Bonds , p. 374, Georg Thieme Publishers, Stuttgart (1979). Specific examples of the γ-keto acids or esters thereof (I) are levulinic acid, 4-oxohexanoic acid, 4-oxoheptanoic acid, 4-oxodecanoic acid, 4-oxododecanoic acid, 4-phenyl-4-oxobutyric acid, 4-p-methoxyphenyl-4-oxobutyric acid, 4-(3,4-dimethoxyphenyl)-4-oxobutyric acid, 4-(3,4,5-trimethoxyphenyl)-4-oxobutyric acid, 4-p-chlorophenyl-4-oxobutyric acid, and 4-phenyl-4-oxobutyric acid; and lower alkyl esters thereof, the alkyl moiety of which preferably has from 1 to 4 carbon atoms, such as methyl and ethyl esters. Optically active ruthenium-phosphine complexes which can be used as a catalyst include:- (1) Compounds represented by formula (III): Ru x H y Cℓ z (R 3 -BINAP) 2 (Q) p wherein R 3 -BINAP represents a tertiary phosphine represented by formula (IV): wherein R 3 represents a hydrogen atom, a methyl group, or a tert-butyl group; Q represents a tertiary amine; y represents 0 or 1; when y is 0, then x represents 2, z represents 4, and p represents 1; and when y is 1, then x represents 1, z represents 1, and p represents 0; (2) Compounds represented by formula (V): wherein R 3 -BINAP is as defined above; R 4 represents a lower alkyl group (e.g., those having from 1 to 4 carbon atoms), a halogenated lower alkyl group (e.g., those having from 1 to 4 carbon atoms), or a phenyl group; and (3) Compounds represented by formula (VI): wherein X represents a halogen atom; R 5 and R 6 , which may be the same or different, each represent a substituted or unsubstituted phenyl group; and R 7 -BINAP represents a tertiary phosphine represented by formula (VII): wherein R 7 represents a hydrogen atom, a methyl group, a tertbutyl group, or a methoxy group. The optically active ruthenium-phosphine complexes (1) of formula (III) can be obtained by, for example, the process disclosed in J. Chem. Soc., Chem. Commun. , p. 922 (1985) or JP-A-61-63690. Specific examples of the complexes (1) are Ru 2 Cℓ 4 (BINAP) 2 (NEt 3 ) (wherein BINAP represents 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl, and Et represents an ethyl group; hereinafter the same), Ru 2 Cℓ 4 (p-Tol-BINAP) 2 (NEt 3 ) (wherein p-Tol-BINAP represents 2,2'-bis(di-p-tolylphosphino)-1,1'-binaphthyl, hereinafter the same), RuHCℓ(BINAP) 2 , and RUHCℓ(p-Tol-BINAP) 2 . The optically active ruthenium-phosphine complexes (2) of formula (V) can be obtained by, for example, the process disclosed in JP-A-62-265293. Specific examples of the complexes (2) are:- (wherein t-Bu represents a tert-butyl group, hereinafter the same), and (wherein Ph represents a phenyl group, hereinafter the same). The optically active ruthenium-phosphine complexes (3) of formula (VI) can be synthesized from, for example, a ruthenium-phosphine complex represented by formula (VIII): wherein R 5 , R 6 , and X are as defined above; and dma represents N,N-dimethylacetamide. In the ruthenium-phosphine complexes of formulae (VI) and (VIII), R 5 and R 6 , which may be the same or different, each represent a substituted or unsubstituted phenyl group, specific examples of which include a phenyl group; an alkyl-substituted phenyl group, e.g., 2-methylphenyl, 3-methylphenyl, and 4-methylphenyl; an alkoxy-substituted phenyl group, e.g., 2-methoxyphenyl, 3-methoxyphenyl, and 4-methoxyphenyl; and a dialkylaminophenyl group, e.g., 2-dimethylaminophenyl, 3-dimethylaminophenyl, and 4-dimethylaminophenyl. Of the compounds represented by formula (VIII), for example, the compound wherein R 5 and R 6 both represent a phenyl group, and X represents a chlorine atom, i.e., [RuCℓ(PPh 3 ) 2 (dma)] 2 (µ-Cℓ) 2 , can be quantitatively prepared as follows. [RuCℓ 3 (PPh 3 ) 2 (dma)](dma) which is obtained, e.g., by the process according to I.S. Thorburn, S.J. Rettig, and B.R. James, Inorg . Chem. , Vol. 25, pp. 234-240 (1986), is reacted in hexane at 60 to 90°C for 1 to 20 hours and, after cooling to room temperature, the reaction mixture is filtered through a glass filter, washed with hexane, and dried. Of the compound represented by formula (VI), the complex wherein R 5 and R 6 both represent a phenyl group, R 7 is a hydrogen atom, and X is a chlorine atom, i.e., [RuCℓ(PPh 3 )-(BINAP)] 2 (µ-Cℓ) 2 , can then be obtained quantitatively by reacting the thus obtained [RuCℓ(PPh 3 ) 2 (dma)] 2 (µ-Cℓ) 2 complex with BINAP in a solvent, e.g., chlorobenzene, o-dichlorobenzene, methylene chloride, and 1,2-dichloroethane, at 50 to 100°C for 5 to 20 hours, followed by removing the solvent by distillation under reduced pressure. The following optically active ruthenium-phosphine complexes included in compounds (3) can also be prepared in the same manner as described above, except for altering the starting material accordingly. [RuCℓ(PPh 3 )(p-Tol-BINAP)] 2 (µ-Cℓ) 2 [RuCℓ(PPh 3 )(p-MeO-BINAP)] 2 (µ-Cℓ) 2 [RuCℓ(PPh 3 )(p-t-Bu-BINAP)] 2 (µ-Cℓ) 2 [RuBr(PPh 3 )(BINAP)] 2 (µ-Br) 2 [RuBr(PPh 3 )(p-Tol-BINAP)] 2 (µ-Br) 2 [RuBr(PPh 3 )(p-MeO-BINAP)] 2 (µ-Br) 2 [RuBr(PPh 3 )(p-t-Bu-BINAP)] 2 (µ-Br) 2 [RuI(PPh 3 )(BINAP)] 2 (µ-I) 2 [RuI(PPh 3 )(p-Tol-BINAP)] 2 (µ-I) 2 [RuI(PPh 3 )(p-MeO-BINAP)] 2 (µ-I) 2 [RuI(PPh 3 )(p-t-Bu-BINAP)] 2 (µ-I) 2 In the above formulae, Ph means a phenyl group; Me means a methyl group; p-Tol-BINAP means 2,2'-bis(di-p-tolylphosphino)-1,1'-binaphthyl; p-MeO-BINAP means 2,2'-bis(di-p-methoxyphenylphosphino)-1,1'-binaphthyl; and p-t-Bu-BINAP means 2,2'-bis(di-p-tert-butylphenylphosphino)-1,1'-binaphthyl. In carrying out the process of the present invention, a γ-keto acid or an ester thereof (I) is dissolved in a solvent, the solution is charged in an autoclave, and an optically active ruthenium-phosphine complex is added to the solution in an amount of from 0.01 to 0.001 mole per mole of the γ-keto acid or ester thereof (I) to conduct enantioselective hydrogenation with stirring at a temperature of from 5 to 50°C, and preferably from 25 to 30°C, under a hydrogen pressure of from 5 to 100 kg/cm 2 for 5 to 300 hours. The product can be isolated from the reaction mixture by removing the solvent and distilling the residue under reduced pressure and/or diluting the residue with a developing solvent, followed by silica gel column chromatography. The present invention has industrial advantages, providing a process for producing an optically active γ-butyrolactone derivative useful as an insect pheromone or a perfume at a satisfactory optical purity through simple operations and a reduced number of steps. The present invention is now illustrated in greater detail with reference to Examples, but it should be understood that the present invention is not construed as being limited thereto. EXAMPLE 1 Synthesis of (R)-4-Methyl-γ-butyrolactone In a 100 mℓ autoclave were charged 2.14 g (14.8 mmole) of ethyl levulinate and 14 mℓ of ethanol, and 21 mg (0.02 mmole) of [RuCℓ(PPh 3 )((R)-BINAP)] 2 (µ-Cℓ) 2 was added to the solution in a nitrogen atmosphere to conduct hydrogenation at 25°C and at a hydrogen pressure of 100 kg/cm 2 for 112 hours. After removing the solvent by distillation, the residue was purified by silica gel column chromatography using hexane-diethyl ether as a developing solvent, and the eluate was heated at 130°C for 4 hours. After cooling to room temperature, the resulting solution was diluted with 4 mℓ of diethyl ether, washed with 3 mℓ of a saturated sodium hydrogencarbonate aqueous solution, and dried over anhydrous sodium sulfate. After separating out the anhydrous sodium sulfate by filtration, the filtrate was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain 1.3 g (percent yield: 88%) of (R)-4-methyl-γ-butyrolactone. b.p.: 90-100°C/25 mmHg [α] 16 / D: +36.8° (c=1.44, CH 2 Cℓ 2 ) 1 H-NMR (400 MHz, CDCℓ 3 , δ ppm): 1.42 (d, 3H, J=6.4 Hz), 1.84 (ddt, 1H, J=7.9 Hz, J=9.4 Hz, J=12.4 Hz), 2.30-2.50 (m, 1H), 2.50-2.60 (m, 2H), 4.66 (ddq, 1H, J=6.2 Hz, J=6.4 Hz, J=7.9 Hz) The product was found to have an optical purity of 99.46%ee by gas chromatography using an optically active capillary column under the following conditions (hereinafter the same): Column: Lipodex® B (produced by Macherey-Nagel Co.); 25 m fused silica Column Temperature: 150°C Column Inlet Temperature: 190°C Carrier Gas: helium EXAMPLE 2 Synthesis of (R)-4-Methyl-γ-butyrolactone In a 100 mℓ autoclave were charged 1.18 g (10 mmole) of methyl levulinate and 15 mℓ of methanol, and 169 mg (0.1 mmole) of Ru 2 Cℓ 4 ((R)-BINAP) 2 NEt 3 was added thereto in a nitrogen atmosphere to conduct hydrogenation at 50°C and at a hydrogen pressure of 100 kg/cm 2 for 20 hours. The reaction mixture was freed of the solvent by distillation and subjected to silica gel column chromatography using hexane-diethyl ether as a developing solvent to remove the catalyst. The eluate was heated at 130°C for 3 hours, followed by cooling to room temperature. The resulting solution was diluted with 4 mℓ of diethyl ether, washed with 3 mℓ of a saturated sodium hydrogencarbonate aqueous solution, and dried over anhydrous sodium sulfate. After separating out the anhydrous sodium sulfate by filteration, the filtrate was concentrated under reduced pressure, and the residue was distilled under reduced pressure to obtain 0.7 g (percent yield: 70%) of (R)-4-methyl-γ-butyrolactone. Optical Purity: 98 %ee [α] 16 / D: +36.2° (c=1.44, CH 2 Cℓ 2 ) EXAMPLE 3 Synthesis of (S)-4-Methyl-γ-butyrolactone In the same manner as in Example 2, except for replacing Ru 2 Cℓ 4 ((R)-BINAP) 2 NEt 3 with Ru 2 Cℓ 4 ((S)-BINAP) 2 NEt 3 , 0.7 g (percent yield: 70%) of (S)-4-methyl-γ-butyrolactone was obtained. Optical Purity: 98 %ee b.p.: 90-100°C/25 mmHg [α] 16 / D: -36.2° (c=1.44, CH 2 Cℓ 2 ) 1 H-NMR (400 MHz, CDCℓ 3 , δ ppm): 1.42 (d, 3H, J=6.4 Hz), 1.84 (ddt, 1H, J=7.9 Hz, J=9.4 Hz, J=12.4 Hz), 2.30-2.50 (m, 1H), 2.50-2.60 (m, 2H), 4.66 (ddq, 1H, J=6.2 Hz, J=6.4 Hz, J=7.9 Hz) EXAMPLE 4 Synthesis of (S)-4-Phenyl-γ-butyrolactone In a 100 mℓ autoclave were charged 1.78 g (10 mmole) of 4-phenyl-4-oxobutyric acid and 14 mℓ of ethanol. A solution separately prepared from 44.9 mg (0.05 mmole) of double the molar quantity of concentrated hydrochloric acid, and 5 mℓ of ethanol was added to the above-prepared solution in a nitrogen atmosphere to conduct hydrogenation at 35°C and at a hydrogen pressure of 70 kg/cm 2 for 230 hours. To the reaction mixture was added 8 mℓ of a 10% sodium hydroxide aqueous solution, followed by stirring at 40°C for 3 hours. After cooling to room temperature, the resulting solution was extracted twice with 30 mℓ portions of methylene chloride. The organic layer was removed, and the aqueous layer was adjusted to a pH of 4 with a 10% hydrochloric acid aqueous solution and then again extracted thrice with 20 mℓ portions of methylene chloride. The combined extract was concentrated, and the residue was purified by silica gel column chromatography using hexane-diethyl ether as a developing solvent to obtain 1.02 g (percent yield: 63%) of (S)-4-phenyl-γ-butyrolactone. Optical Purity: 96.7 %ee b.p.: 85-95°C/0.1 mmHg [α] 16 / D: -31.4° (c=3.88, CHCℓ 3 ) 1 H-NMR (400 MHz, CDCℓ 3 , δ ppm): 1.8-3.0 (m, 4H, CH 2 CH 2 ), 5.57 (t, 1H, J=7 Hz, CH), 7.45 (s, 5H, Ph) EXAMPLES 5 TO 8 Compounds shown in Table 1 below were synthesized in the same manner as in Example 4, except for using the indicated γ-keto acid or ester, changing the reaction conditions (substrate/catalyst molar ratio, temperature, time, and solvent) as shown in Table 1, and changing the hydrogen pressure from 70 kg/cm 2 to 100 kg/cm 2 .

Claims: A process for producing an optically active γ-butyrolactone derivative represented by the following general formula (II): wherein R 1 represents an alkyl group having from 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group; and * indicates an asymmetric carbon atom, which comprises enantioselectively hydrogenating a γ-keto acid or an ester thereof represented by the following general formula (I): wherein R 1 and * are as defined above; and R 2 represents a hydrogen atom or a lower alkyl group, in the presence of an optically active ruthenium-phosphine complex. A process as claimed in Claim 1, wherein said optically active ruthenium-phosphine complex is selected from compounds represented by the following general formulae (III), (V), or (VI): Ru x H y Cℓ z (R 3 -BINAP) 2 (Q) p wherein R 3 -BINAP represents a tertiary phosphine represented by formula (IV): wherein R 3 represents a hydrogen atom, a methyl group, or a tert-butyl group; Q represents a tertiary amine; y represents 0 or 1; when y is 0, then x represents 2, z represents 4, and p represents 1; and when y is 1, then x represents 1, z represents 1, and p represents 0: wherein R 3 -BINAP is as defined above; R 4 represents a lower alkyl group, a halogenated lower alkyl group, or a phenyl group; and wherein X represents a halogen atom; R 5 and R 6 , which may be the same or different, each represent a substituted or unsubstituted phenyl group; R 7 -BINAP represents a tertiary phosphine represented by formula (VII): wherein R 7 represents a hydrogen atom, a methyl group, a tertbutyl group, or a methoxy group. A process as claimed in Claims 1 or 2, wherein R 1 represents an alkyl group having from 1 to 4 carbon atoms.

Inventors: KITAMURA MASATO, KUMOBAYASHI HIDENORI, NOYORI RYOJI, OHKUMA TAKESHI, SAYO NOBORU, KITAMURA, MASATO, KUMOBAYASHI, HIDENORI, NOYORI, RYOJI, OHKUMA, TAKESHI, SAYO, NOBORU, KUMOBAYASHI, HIDENORI, C/O TAKASAGO RESEARCH INST., Sayo, Noboru, c/o Takasago Research Inst. Inc.
Applicants: TAKASAGO PERFUMERY CO LTD, TAKASAGO INTERNATIONAL CORPORATION
Application year: 1991
Main classification: C07D307
IPC codes: C07B61, C07D315, B01J31, C07B53, C07D307